Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PAHC | US
-1.67
-3.37%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
06/03/2026
47.92
48.70
49.42
47.16
Phibro Animal Health Corporation develops manufactures and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health Mineral Nutrition and Performance Products. The company develops manufactures and markets products for poultry swine beef and dairy cattle aquaculture and dogs. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. The company also offers nutritional specialty products which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. In addition it manufactures and markets formulations and concentrations of trace minerals such as zinc manganese copper iron and other compounds; and various specialty ingredients for use in the personal care industrial chemical and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry swine and cattle integrators as well as through commercial animal feed manufacturers wholesalers and distributors. It operates in the United States Latin America Canada Europe the Middle East Africa and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck New Jersey.
View LessLow Market Beta (-0.4 to 0.8)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
Smallcap (300M - 2B USD)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Operating Margin (< 10%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
42.7%1 month
84.8%3 months
59.4%6 months
49.6%401.17
10.57
3.80
2.05
0.53
20.07
1.36
1.66
94.08M
1.94B
1.94B
1.99
8.57
-93.50
7.10
0.90
1.82
2.71
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
8.83
Range1M
16.00
Range3M
20.16
Rel. volume
0.67
Price X volume
10.06M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Bausch Health Companies Inc | BHC | Drug Manufacturers-Specialty & Generic | 5.38 | 1.98B | -3.41% | n/a | -1843.40% |
| Perrigo Company plc | PRGO | Drug Manufacturers-Specialty & Generic | 10.72 | 1.46B | -4.29% | n/a | 93.52% |
| Harrow Health Inc | HROW | Drug Manufacturers-Specialty & Generic | 36.35 | 1.29B | 0.50% | n/a | 331.16% |
| Alvotech Ordinary Shares | ALVO | Drug Manufacturers-Specialty & Generic | 4.01 | 1.21B | -3.61% | n/a | -196.14% |
| Collegium Pharmaceutical Inc | COLL | Drug Manufacturers-Specialty & Generic | 37.29 | 1.20B | 0.03% | 14.45 | 258.31% |
| Assertio Therapeutics Inc | ASRT | Drug Manufacturers-Specialty & Generic | 11.72 | 1.12B | -1.92% | n/a | 30.76% |
| Karyopharm Therapeutics Inc | KPTI | Drug Manufacturers-Specialty & Generic | 8.77 | 1.09B | -0.57% | n/a | -148.05% |
| Pacira Pharmaceuticals Inc | PCRX | Drug Manufacturers-Specialty & Generic | 22 | 1.01B | -3.76% | 13.05 | 73.76% |
| Amphastar Pharmaceuticals Inc | AMPH | Drug Manufacturers-Specialty & Generic | 19.34 | 946.93M | -5.38% | 16.14 | 87.00% |
| OPKO Health Inc | OPK | Drug Manufacturers-Specialty & Generic | 1.18 | 816.54M | 0.85% | n/a | 19.31% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| HNI Corporation | HNI | Building Products & Equipment | 41.44 | 1.95B | -2.61% | 22.12 | 76.47% |
| Pitney Bowes Inc | PBI | Building Products & Equipment | 10.58 | 1.90B | -2.76% | n/a | -571.93% |
| Albany International Corp | AIN | Textile Manufacturing | 58.44 | 1.83B | -1.53% | 21.29 | 38.97% |
| Interface Inc | TILE | Textile Manufacturing | 28.14 | 1.64B | 0.00% | 17.81 | 106.26% |
| ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 13.9 | 1.39B | -2.32% | n/a | 19.46% |
| Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 35.84 | 1.13B | -0.28% | 51.60 | 88.92% |
| Winnebago Industries Inc | WGO | Recreational Vehicles | 36.29 | 1.05B | -4.63% | 22.53 | 56.33% |
| Janus International Group Inc. | JBI | Building Products & Equipment | 5.29 | 768.75M | -9.26% | 11.62 | 116.21% |
| Latham Group Inc. | SWIM | Building Products & Equipment | 6.3 | 728.14M | -2.48% | 65.18 | 77.00% |
| Fox Factory Holding Corp | FOXF | Recreational Vehicles | 16.31 | 679.85M | -6.91% | 42.05 | 64.69% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 20.07 | 24.85 | Par |
| Ent. to Revenue | 1.36 | 361.91 | Cheaper |
| PE Ratio | 401.17 | 30.05 | Expensive |
| Price to Book | 3.80 | 13.15 | Cheaper |
| Dividend Yield | 1.99 | 2.94 | Poor |
| Std. Deviation (3M) | 59.41 | 65.24 | Par |
| Debt to Equity | 2.05 | -1.88 | Expensive |
| Debt to Assets | 0.53 | 0.48 | Par |
| Market Cap | 1.94B | 3.71B | Emerging |